Imagine a world where the very essence of life—genes, species, and the building blocks of nature—can be claimed, bought, and ...

An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ...

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

Duke University will award honorary degrees to Dr. Rebecca Buckley ’54, David Robinson II ’64 and Dr. Feng Zhang during its ...

Most cells in the human body each contain about six feet of DNA. Yet the nucleus, where DNA is coiled, is no larger than a ...

Just because scientists claim they have now brought back the extinct dire wolf, should we consider ‘bringing back’ more ...

BofA lowered the firm’s price target on Crispr Therapeutics (CRSP) to $80 from $86 and keeps a Buy rating on the shares. While Q1 earnings ...

The prospects for a one-time treatment that reduces the risk of heart disease for the rest of a person’s life just got brighter. In an initial trial, a single dose of a CRISPR gene-editing therapy ...

Under Reshma Kewalramani's leadership, Vertex achieved a major milestone with the FDA’s first-ever approval of a CRISPR-based ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.